Avicanna Inc. (OTCMKTS:AVCNF) Short Interest Update

Avicanna Inc. (OTCMKTS:AVCNF – Get Free Report) was the recipient of a significant increase in short interest in the month of August. As of August 31st, there was short interest totaling 38,879 shares, an increase of ∞ from the August 15th total of 0 shares. Based on an average daily volume of 32,741 shares, the days-to-cover ratio is currently 1.2 days.

Avicanna Price Performance

Shares of OTCMKTS:AVCNF opened at $0.09 on Wednesday. The company has a 50 day moving average price of $0.09 and a two-hundred day moving average price of $0.10. Avicanna has a 52 week low of $0.07 and a 52 week high of $0.22.

Get Avicanna alerts:

About Avicanna

(Get Free Report)

Avicanna Inc, a commercial-stage biopharmaceutical company, engages in the research, development, advancement, and commercialization of evidence-based cannabinoid-based products and formulations for consumer, medical, and pharmaceutical markets worldwide. It commercializes approximately thirty proprietary evidence-based finished products. The company provides medical cannabis formulary products, including oral, sublingual, topical, and transdermal deliveries with various ratios of cannabinoids under the RHO Phyto brand; and indication-specific pharmaceutical products to address unmet medical needs in the areas of dermatology, chronic pain, and various neurological disorders, such as Trunerox, an adjuvant treatment for seizures associated with Lennox-Gastaut Syndrome and Dravet Syndrome.

See Also

• Five stocks we like better than Avicanna
• 2 “Cheap for a Reason” Airline Stocks That May Be Worth the Risk
• Running on Empty: 3 Energy Plays for Europe’s Deep Freeze
• 3 Healthcare Stocks for 3 Stages of Life
• Curaleaf Tries To Roll Up Aurora In a Hostile Cannabis Bid

Receive News & Ratings for Avicanna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avicanna and related companies with MarketBeat.com's FREE daily email newsletter.